Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
7 hedge funds and large institutions have $91K invested in Timber Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
0% more funds holding
Funds holding: 7 → 7 (0)
37% less capital invested
Capital invested by funds: $145K → $91K (-$53.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$9.95K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$9.44K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$4.59K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$2.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$12K |
| 2 |
NFG
Norris Financial Group
Greenville,
South Carolina
|
-$5.51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Barclays
London,
United Kingdom
| $37K | – | – | – |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $23K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $11K | +$9.95K | +39 | +205% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $8K | – | – | – |
|
|
5
Northern Trust
Chicago,
Illinois
| $7K | +$9.44K | +37 | New |
|
|
6
Bank of America
Charlotte,
North Carolina
| $3K | +$4.59K | +18 | New |
|
|
7
Victory Capital Management
San Antonio,
Texas
| $2K | +$2.04K | +8 | New |
|
|
8
Renaissance Technologies
New York
| – | -$12K | -48 | Closed |
|
|
NFG
9
Norris Financial Group
Greenville,
South Carolina
| – | -$5.51K | -22 | Closed |
|
TMBR Hedge Fund Activity: Q1 2020 in Review
7 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q1 2020, worth a combined $91K — down 37% from $145K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TMBR positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $9.95K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $12K sold.
- 7 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $91K of Timber Pharmaceuticals, Inc. stock for Q1 2020, down 37% quarter-over-quarter.
- 3 funds opened new Timber Pharmaceuticals, Inc. positions in Q1 2020 and 2 closed out, a net change of +1 holder.
- The largest Timber Pharmaceuticals, Inc. buyer in Q1 2020 was UBS Group, an estimated $9.95K added.
- The largest Timber Pharmaceuticals, Inc. seller in Q1 2020 was Renaissance Technologies, an estimated $12K sold.
Based on aggregated 13F filings for Q1 2020.